OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves modifying various parameters, including cell line engineering, media formulation, and bioreactor environments. A key goal is to maximize antibody production while lowering product